Side effects for GLP-1s may include nausea, vomiting, stomach pain, upset stomach, dizziness, constipation, feeling bloated, belching, gas, headaches and fatigue
GLP-1 receptor agonists have become some of the most talked-about medications in primary care
Aging Cell
Furthermore, clinical research has shown that insulin therapy improves cognitive performance in both T2DM and AD, indicating that poor insulin signaling may be a major contributor to diabetic cognitive impairment (Novak et al., 2014
Drugwatch has provided people injured by harmful drugs and devices with reliable answers and experienced legal help since 2009
Mounjaro and Zepbound are the same compound: tirzepatide